You are here

Article Text

Article menu
Download PDFPDF
REVIEW ARTICLE
Hormone replacement therapy on ovarian and uterine cancer risk and cancer survivors: how shall we do no harm?
  1. V. Loizzi,
  2. G. Cormio,
  3. M. Vicino,
  4. N. Fattizzi,
  5. S. Bettocchi and
  6. L. Selvaggi
  1. Department of Obstetrics and Gynecology, University of Bari, Bari, Italy
  1. Address correspondence and reprint requests to: Vera Loizzi, MD, Department of Obstetrics and Gynecology, University of Bari, Piazza Giulio Cesare, 11, 70124 Bari, Italy. Email: vloizzi{at}tiscali.it

Abstract

This article will focus on the results of the Women's Health Initiative on the effects of hormone replacement therapy on coronary heart disease, stroke, venous thromboembolism, breast cancer, and colorectal cancer. Data from other relevant trials, including the most recent data on ovarian and uterine cancer risk and on gynecologic cancer patients, are also discussed to provide some guidelines on prescribing hormone replacement therapy in clinical practice, particularly in gynecologic cancer survivors.

  • hormone replacement therapy
  • ovarian and endometrial cancer

https://doi.org/10.1136/ijgc-00009577-200505000-00002

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.